Chloe Sligar

Wollongong, NSW 2522, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Immune imbalance between T helper 1, T helper 17 and regulatory T cells fuels amyotrophic lateral sclerosis pathogenesis: disease trajectory, diagnosis and therapeutic implications.

Immune imbalance between T helper 1, T helper 17 and regulatory T cells fuels amyotrophic lateral sclerosis pathogenesis: disease trajectory, diagnosis and therapeutic implications.

Journal: Journal of neuroinflammation

Published: November 21, 2025

Adeno-associated viral vectors encoding anti-P2X7 nanobodies reduce graft-versus-host disease in a humanised mouse model.

Adeno-associated viral vectors encoding anti-P2X7 nanobodies reduce graft-versus-host disease in a humanised mouse model.

Journal: Clinical & translational immunology

Published: June 26, 2025

Low- and high-dose post-transplant cyclophosphamide attenuates graft-versus-host disease with distinct effects on PD-1+ T cell subsets.

Low- and high-dose post-transplant cyclophosphamide attenuates graft-versus-host disease with distinct effects on PD-1+ T cell subsets.

Journal: Clinical science (London, England : 1979)

Published: June 02, 2025

Use of Human Chronic Myeloid Leukemia Cells to Study Graft-Versus-Leukemia Immunity in a Xenogeneic Mouse Model of Graft-Versus-Host Disease.

Use of Human Chronic Myeloid Leukemia Cells to Study Graft-Versus-Leukemia Immunity in a Xenogeneic Mouse Model of Graft-Versus-Host Disease.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 18, 2025

Xenogeneic Animal Models of Graft-Versus-Host Disease.

Xenogeneic Animal Models of Graft-Versus-Host Disease.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 18, 2025

Humanized Mouse Model of Graft-Versus-Host Disease Utilizing Nonirradiated NOD-scid-IL-2Rγnull Mice.

Humanized Mouse Model of Graft-Versus-Host Disease Utilizing Nonirradiated NOD-scid-IL-2Rγnull Mice.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 18, 2025

Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice.

Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice.

Journal: International journal of molecular sciences

Published: November 28, 2023

Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised mice.

Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised mice.

Journal: Clinical & translational immunology

Published: November 21, 2023

A Species-Specific Anti-Human P2X7 Monoclonal Antibody Reduces Graft-versus-Host Disease in Humanised Mice.

A Species-Specific Anti-Human P2X7 Monoclonal Antibody Reduces Graft-versus-Host Disease in Humanised Mice.

Journal: Pharmaceutics

Published: July 13, 2023

Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft-versus-host disease development in humanized mice treated with post-transplant cyclophosphamide.

Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft-versus-host disease development in humanized mice treated with post-transplant cyclophosphamide.

Journal: Immunology and cell biology

Published: December 14, 2022

Purinergic signalling in graft-versus-host disease.

Purinergic signalling in graft-versus-host disease.

Journal: Current opinion in pharmacology

Published: September 12, 2022

Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host Disease.

Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host Disease.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 01, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026